MA42521A - Système d'administration transdermique - Google Patents

Système d'administration transdermique

Info

Publication number
MA42521A
MA42521A MA042521A MA42521A MA42521A MA 42521 A MA42521 A MA 42521A MA 042521 A MA042521 A MA 042521A MA 42521 A MA42521 A MA 42521A MA 42521 A MA42521 A MA 42521A
Authority
MA
Morocco
Prior art keywords
delivery system
transdermal delivery
transdermal
delivery
Prior art date
Application number
MA042521A
Other languages
English (en)
Inventor
Deborah Phyllis Harding
Helen Johnson
Gill Mundin
Kevin Smith
Steve Whitelock
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of MA42521A publication Critical patent/MA42521A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA042521A 2015-07-30 2016-07-28 Système d'administration transdermique MA42521A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1513441.4A GB201513441D0 (en) 2015-07-30 2015-07-30 Transdermal delivery system

Publications (1)

Publication Number Publication Date
MA42521A true MA42521A (fr) 2018-06-06

Family

ID=54062902

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042521A MA42521A (fr) 2015-07-30 2016-07-28 Système d'administration transdermique

Country Status (16)

Country Link
US (1) US20180221299A1 (fr)
EP (1) EP3328431A1 (fr)
JP (1) JP2018528175A (fr)
KR (1) KR20180035859A (fr)
CN (1) CN108025077A (fr)
AR (1) AR105533A1 (fr)
AU (1) AU2016298761A1 (fr)
BR (1) BR112018001615A2 (fr)
CA (1) CA2994103A1 (fr)
GB (1) GB201513441D0 (fr)
IL (1) IL256995A (fr)
MA (1) MA42521A (fr)
MX (1) MX2018001318A (fr)
SG (1) SG10201913254RA (fr)
TW (1) TW201713340A (fr)
WO (1) WO2017017452A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10231248A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk ジヒドロエトルフィン含有経皮吸収型製剤
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
RS20050812A (sr) * 2003-04-30 2007-12-31 Purdue Pharma L.P., Transdermalni dozni oblik otporan na promene
TWI541246B (zh) * 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡

Also Published As

Publication number Publication date
US20180221299A1 (en) 2018-08-09
MX2018001318A (es) 2018-08-15
JP2018528175A (ja) 2018-09-27
GB201513441D0 (en) 2015-09-16
AU2016298761A1 (en) 2018-02-15
WO2017017452A1 (fr) 2017-02-02
EP3328431A1 (fr) 2018-06-06
CA2994103A1 (fr) 2017-02-02
IL256995A (en) 2018-03-29
BR112018001615A2 (pt) 2018-09-18
TW201713340A (zh) 2017-04-16
SG10201913254RA (en) 2020-03-30
AR105533A1 (es) 2017-10-11
KR20180035859A (ko) 2018-04-06
CN108025077A (zh) 2018-05-11

Similar Documents

Publication Publication Date Title
EP3297620A4 (fr) Système d'administration transdermique de la kétamine
EP3380061A4 (fr) Système d'administration de médicament automatisé portable
EP3435978A4 (fr) Système d'administration
EP3389557A4 (fr) Système d'administration trans-septale
EP3294398A4 (fr) Systèmes et procédés d'administration de médicaments
EP3302399A4 (fr) Système modulaire de distribution de médicaments
DK3368108T3 (da) Medikamenttilførselsanordning
EP3589341A4 (fr) Système d'administration de médicament commandé à distance
EP3349670A4 (fr) Système de délivrance amovible
DK3493862T3 (da) Lægemiddelindgivelsesanordning
DK3302638T3 (da) Anordning til indgivelse af lægemidler
EP3346998A4 (fr) Système d'administration de film par voie topique
EP3302087A4 (fr) Système d'infusion
EP3231467C0 (fr) Système de pompe à infusion
DK3380139T3 (da) Medikamentadministrationsanordning
EP3445416A4 (fr) Système d'administration entérale de médicaments
EP3373908A4 (fr) Systèmes d'administration de probiotiques
DK3380146T3 (da) Medikamentadministrationsanordning
EP3348648A4 (fr) Véhicule d'administration intracellulaire
DK3558423T3 (da) Medikamentadministrationsanordning
DK3558438T3 (da) Lægemiddelindgivelsesanordning
EP3244868C0 (fr) Dispositifs d'administration de médicaments
EP3354128A4 (fr) Système d'irrigation
DK3570911T3 (da) Medikamenttilførselsanordning
EP3359994A4 (fr) Système d'autopropulsion